Han Jie Lee

Singapore General Hospital

Papers

1

Total Citations

23

H-Index

1

About

Dr. Han Jie Lee is a pioneering urological researcher whose work centers on advancing prostate cancer diagnostics through precision image-guided biopsy techniques. His most influential study, published in 2020, evaluated the efficacy of multiparametric MRI-ultrasonography software fusion using a stereotactic robotic-assisted transperineal platform—a cutting-edge approach that enhances targeting accuracy while reducing procedural invasiveness. By systematically comparing targeted versus systematic biopsy outcomes in patients with suspicious lesions on multiparametric MRI, Dr. Lee provided critical evidence that targeted biopsy alone can achieve comparable or superior cancer detection rates, potentially sparing patients from unnecessary sampling. This work, cited 23 times, has informed evolving clinical guidelines and fueled broader adoption of fusion-guided biopsy protocols. Dr. Lee’s contributions sit at the intersection of radiology, robotics, and oncology, demonstrating how technological integration can improve diagnostic precision and patient experience. His research continues to shape the future of minimally invasive prostate cancer detection, offering a compelling model for evidence-based innovation in urological practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy
23 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Singapore General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago